THC Tolerance Did Not Uniformly Protect Cellular Immune Measures in Female Mice
Female mice tolerant to THC's temperature and antinociceptive effects still showed changes in selected immune measures. After cessation, additional immune differences appeared, while several other measures remained unchanged.
Behavioral tolerance was established separately
Female B6C3F1 mice received repeated THC for four days. Testing demonstrated tolerance to antinociception and hypothermia. The researchers then examined immune-related outcomes in tolerant and abstinent animals. Demonstrated tolerance on those behavioral measures did not establish adaptation in every cell population.
The immune findings were selective
Interleukin-2 production was suppressed in both tolerant and abstinent mice. Interleukin-4 and cytotoxic-cell responses showed significant suppression only in abstinent animals. Spleen weight and cellularity decreased after cessation, whereas body weight, thymus measures and B-cell proliferation did not show the reported significant changes.
Cell assays do not measure clinical infection risk directly
These outcomes concern specified immune functions and tissues. They do not establish that cannabis users develop a particular infection or that withdrawal produces generalized immune failure. The abstinent exposure state also needs to remain distinct from an ongoing THC challenge.
The experiment shows why one unchanged immune measure cannot represent the whole immune system, and why behavioral tolerance cannot stand in for immune tolerance. Its conclusions are limited to a short injected-THC regimen in female mice, without establishing a human clinical risk magnitude or treatment recommendation.
Related: interpreting cannabis tolerance claims.
Research cited
Bhargava HN; House RV; Thorat SN; Thomas PT. Cellular immune function in mice tolerant to or abstinent from l-trans-delta 9-tetrahydrocannabinol. Pharmacology (1996). doi:10.1159/000139392. Findings discussed from the study abstract.
